Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2015 May;27(5):594-609.
doi: 10.1111/nmo.12520. Epub 2015 Apr 1.

ANMS-ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders

Affiliations
Practice Guideline

ANMS-ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders

S S C Rao et al. Neurogastroenterol Motil. 2015 May.

Abstract

Background: Anorectal disorders such as dyssynergic defecation, fecal incontinence, levator ani syndrome, and solitary rectal ulcer syndrome are common, and affect both the adult and pediatric populations. Although they are treated with several treatment approaches, over the last two decades, biofeedback therapy using visual and verbal feedback techniques has emerged as an useful option. Because it is safe, it is commonly recommended. However, the clinical efficacy of biofeedback therapy in adults and children is not clearly known, and there is a lack of critical appraisal of the techniques used and the outcomes of biofeedback therapy for these disorders.

Purpose: The American Neurogastroenterology and Motility Society and the European Society of Neurogastroenterology and Motility convened a task force to examine the indications, study performance characteristics, methodologies used, and the efficacy of biofeedback therapy, and to provide evidence-based recommendations. Based on the strength of evidence, biofeedback therapy is recommended for the short-term and long-term treatment of constipation with dyssynergic defecation (Level I, Grade A), and for the treatment of fecal incontinence (Level II, Grade B). Biofeedback therapy may be useful in the short-term treatment of Levator Ani Syndrome with dyssynergic defecation (Level II, Grade B), and solitary rectal ulcer syndrome with dyssynergic defecation (Level III, Grade C), but the evidence is fair. Evidence does not support the use of biofeedback for the treatment of childhood constipation (Level 1, Grade D).

Keywords: biofeedback therapy; constipation; dyssynergic defecation; fecal incontinence; levator ani syndrome.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: Dr Rao reports no conflict of interest in the context of this report but has served as a consultant for Forest laboratories, Ironwood pharmaceuticals, Takeda pharmaceuticals, Salix pharmaceuticals and Given imaging. Dr Benninga reports no conflict of interest in the context of this report, but he serves as a consultant for Shire, Sucampo and Johnson and Johnson pharmaceuticals. Dr Bharucha served as a consultant for Uroplasty Inc, Gicare Pharma, Furiex Pharmaceuticals. Dr Chiarioni served as a speaker for Shire Italia S.P.A. Dr. Di Lorenzo reports no conflict of in interest in the context of this report, but he is consultant for QOL, Sucampo Pharmaceuticals and Ironwood Pharmaceuticals.

Figures

Fig 1
Fig 1
The rectal and anal pressure changes, and manometric patterns in a patient with constipation and dyssynergic defecation, before and after biofeedback showing paradoxical anal contraction at baseline that improved after 5 sessions of biofeedback therapy
Fig 2
Fig 2
B. The anorectal pressure changes in the same patient (2A) after 4 sessions of biofeedback therapy for fecal incontinence. The patient now demonstrates a coordinated squeeze response with a significant and sustained increase in the anal sphincter pressure, and without any rise in intrarectal pressure.

References

    1. Wald AB, Bharucha A, Cosman BC, et al. ACG clinical guidelines: management of benign anorectal disorders. Am J Gastroenterol. 2014 (in press) - PubMed
    1. Rao SS. Current and emerging treatment options for fecal incontinence. J Clin Gastroenterol. 2014;48:752–764. - PMC - PubMed
    1. Mugie SM, Di LC, Benninga MA. Constipation in childhood. Nat Rev Gastroenterol Hepatol. 2011;8:502–511. - PubMed
    1. Whitehead WE, Rao SS, Lowry A, et al. Treatment of fecal incontinence: State of the Science and directions for future research. Am J Gastroenterol. 2015 (in press) - PubMed
    1. Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20:21–35. - PubMed

Publication types

Supplementary concepts